SunWay Biotech Co., Ltd. (1271) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for SunWay Biotech Co., Ltd. (1271:TWSE), powered by AI.

Current Price
$64.20
Sector
Consumer Defensive
What is the SunWay Biotech Co., Ltd. stock price forecast?

SunWay Biotech Co., Ltd. is currently trading at $64.20. View real-time AI analysis on Alpha Lenz.

What is SunWay Biotech Co., Ltd. insider trading activity?

View the latest insider trading data for SunWay Biotech Co., Ltd. on Alpha Lenz.

What is SunWay Biotech Co., Ltd.'s P/E ratio?

View SunWay Biotech Co., Ltd.'s valuation metrics on Alpha Lenz.

SunWay Biotech Co., Ltd.

TWSE · 1271
NT$64.20-0.30(-0.47%)
Ask about SunWay Biotech Co., Ltd.'s future dividend policy...
Alpha Chat Insight

SunWay Biotech Co., Ltd.'s ROE is 3.1%. Explore profitability and growth together.

Ask for details

Company Overview

SunWay Biotech Co., Ltd. is a biotechnology company specializing in the research, development, and production of health food products. Established in 2007 and headquartered in Taipei, the company’s core offerings include advanced functional ingredients like Monascus purpureus NTU 568 (a patented red yeast product) and Lactobacillus paracasei NTU 101, both of which target digestive health, immune support, and allergy regulation. Its portfolio extends to probiotic-based foods, raw materials, and nutraceutical ingredients used by both consumers and the broader food industry. Operating primarily in the health technology and packaged foods sectors, SunWay Biotech serves domestic and international markets, reflecting Taiwan’s growing presence in the global functional foods industry. The company’s strong focus on innovation and R&D underpins its reputation for scientific excellence, while its financial structure—marked by a high gross margin and low debt—supports its stable position in the competitive biotechnology landscape. SunWay Biotech’s health-oriented products contribute to the expanding sector of preventive healthcare and wellness-driven consumer preferences.

SectorConsumer Defensive
IndustryPackaged Foods
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$993.30MRevenue
0.00Shares Out
0Employees

Margins

56.43%Gross
19.88%EBITDA
10.48%Operating
11.62%Pre-Tax
10.22%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

32.67%Rev 3Yr
25.86%Rev 5Yr
38.89%Op Inc 3Yr
-3.72%Op Inc 5Yr
47.94%Net Inc 3Yr
-4.19%Net Inc 5Yr

Returns

2.46%ROA
3.11%ROE
3.07%ROIC

Financial Health

NT$301.02MCash & Cash Equivalents
NT$896.97MNet Debt
36.70%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

SunWay Biotech Co., Ltd. (ticker: 1271) is a company listed on TWSE in the Consumer Defensive sector (Packaged Foods).

The current price is 64.2 with a P/E ratio of -x and P/B of -x.

ROE is 3.11% and operating margin is 10.48%. Annual revenue is $993M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
SunWay Biotech Co., Ltd. (1271) Stock Forecast 2026 $64.20 — Price, Financials & Analyst Targets | Alpha Lenz